Main Session
Sep
27
SS 02 - Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care
108 - Three-Year Outcomes of a Prospective Randomized Trial of Moderately-Hypofractionated and Standard-Fractionated Proton Therapy in Prostate Cancer Embedded within COMPPARE Trial
Presenter(s)
Nancy Mendenhall, MD, FASTRO - University of Florida Proton Therapy Institute, Jacksonville, FL